ENANTIOSELECTIVE SYNTHESIS OF THE 4 ISOMERS OF THE BIOLOGICALLY-ACTIVE METABOLITE OF THE 2-ARYLPROPANOIC ACID NSAID, XIMOPROFEN, AND ASSESSMENT OF THEIR INHIBITORY ACTIVITY ON HUMAN PLATELET CYCLOOXYGENASE IN-VITRO
Dpg. Hamon et al., ENANTIOSELECTIVE SYNTHESIS OF THE 4 ISOMERS OF THE BIOLOGICALLY-ACTIVE METABOLITE OF THE 2-ARYLPROPANOIC ACID NSAID, XIMOPROFEN, AND ASSESSMENT OF THEIR INHIBITORY ACTIVITY ON HUMAN PLATELET CYCLOOXYGENASE IN-VITRO, Tetrahedron : asymmetry, 7(1), 1996, pp. 263-272
The four stereoisomers of the parent keto acid of the oximino drug xim
oprofen have been prepared in high enantiomeric purity. The stereochem
istry in the propionic acid chain was established by the combination o
f Sharpless epoxidation followed by stereoselective hydrogenolysis of
the benzylic carbon-oxygen bond with inversion of configuration. The s
tereochemistry of the centre in the cyclohexanone ring was controlled
by the stereoselective conjugate addition of the arylpropanoic acid mo
iety to the enantiomers of 5-(trimethylsilyl)-2-cyclohexenone with sub
sequent removal of the trimethylsilyl group. The pharmacological activ
ity of each of the four isomers of the keto acid parent of ximoprofen
were assessed by their in vitro inhibition of human platelet cyclo-oxy
genase. As expected, the (S) configuration of the propionic acid chain
was essential for activity but it was also found that the stereochemi
stry in the cyclohexanone moiety was important. Attempts to separate t
he (E) and (Z) isomers of the oxime derivative from one of the stereoi
somers were unsuccessful.